Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mitochondrial electron transport chain (ETC) and outer membrane integrity represent a critical functional system that integrates cellular energy production with the regulation of programmed cell death (PubMed, 2023). The ETC consists of a series of protein complexes (I-IV) and electron carriers located in the inner mitochondrial membrane that facilitate oxidative phosphorylation to generate ATP (NIH, 2024). Maintaining the integrity of the mitochondrial outer membrane is essential to prevent the release of pro-apoptotic factors, such as cytochrome c, into the cytosol—a process primarily governed by the BCL-2 protein family and the mitochondrial permeability transition pore (mPTP) (StatPearls, 2023). Dysregulation of this system, characterized by reduced ATP synthesis, increased reactive oxygen species (ROS) production, and premature membrane permeabilization, is a hallmark of various pathologies, including neurodegenerative diseases, cardiovascular disorders, and ischemia-reperfusion injury (PubMed, 2023). Therapeutic strategies targeting this system include stabilizing mitochondrial membranes (e.g., via cardiolipin-binding agents like elamipretide) to enhance bioenergetics or inducing membrane permeabilization (e.g., via BCL-2 inhibitors) to trigger apoptosis in malignant cells (PubMed, 2023).
Stabilization of cardiolipin to optimize electron transport and prevent cytochrome c release; inhibition of respiratory chain complexes (I-IV); modulation of BCL-2 family proteins to regulate outer membrane permeabilization; and inhibition of the mitochondrial permeability transition pore (mPTP).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial electron transport chain and outer membrane integrity (ETC/MOM).